Haemonetics HAE
$120.16 −$0.21 (-0.17%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $120.16 0.00%
Open$120.37
Prev close$120.37
Day range$119.68 – $122.34
Volume383.0K
Market cap$5.47B
P/E (TTM)53.2
Dividend yield–
HAE Stock News
Headlines matching Haemonetics or the HAE ticker, most recent first.
- Raymond James Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $125 Positive
- Citi Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $123
- Citi Upgrades Haemonetics(HAE.US) to Buy Rating, Raises Target Price to $123 Positive
- A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $92 to $105
- A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $92 to $96
- Hae In: Report on significant holdings of stocks, etc. (General)
- Baird Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $119 Positive
- Barrington Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $118 Positive
- Needham Maintains Haemonetics(HAE.US) With Hold Rating
- BofA Securities Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $120 Positive
- BofA Securities Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $120
- Citi Maintains Haemonetics(HAE.US) With Hold Rating, Maintains Target Price $92
- Mizuho Securities Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $95 Positive
- BofA Securities Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $100 Positive
- J.P. Morgan Sticks to Its Hold Rating for Haemonetics (HAE)
No comments yet — be the first to weigh in on HAE.
Sign in to join the discussion.